Table 4.
Variable | Categorization | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
P value | HR | 95% CI | P value | ||
Sex | female, male | 0.526 | |||
Age | ≤56, >56 | 0.630 | |||
HBsAg | negative, positive | 0.026* | |||
intrahepatic biliary stones | negative, positive | 0.501 | |||
Tumour diameter, cm | ≤5, >5 | 0.106 | |||
Surgical procedure | nonanatomical, anatomical | 0.477 | |||
Complications | 0.154 | ||||
No complication | |||||
Clavien-Dindo grade I-II | |||||
Clavien-Dindo grade III-IV | |||||
Tumour differentiation | poor, others | 0.266 | |||
Vascular invasion | absent, present | 0.007* | |||
Perineural invasion | absent, present | 0.468 | |||
Periductal invasion | absent, present | 0.142 | |||
Surgical margin | negative, positive | 0.844 | |||
Lymph node metastasis | absent, present | 0.011* | 1.972 | 1.039–3.743 | 0.038* |
Pathological cirrhosis | absent, present | 0.389 | |||
antiviral therapy | no, yes | 0.979 | |||
Adjuvant therapy | no, yes | 0.550 |
* indicates statistically significant.
HBsAg, hepatitis B virus surface antigen; HR, hazard ratio; ICC, intrahepatic cholangiocarcinoma; OS, overall survival.